IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC

被引:38
作者
GHETIE, V
VITETTA, E
机构
[1] UNIV TEXAS, SW MED CTR, DEPT MICROBIOL, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, CTR CANC IMMUNOBIOL, DALLAS, TX 75235 USA
关键词
IMMUNOTOXIN; MONOCLONAL ANTIBODY; CANCER; THERAPY;
D O I
10.1016/0163-7258(94)90025-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review presents only those contributions that have progressed from the bench to the clinic using murine monoclonal antibodies coupled chemically to toxins, their subunits or ribosome-inactivating proteins. The rationale and progress in the development, characterization, preclinical testing and clinical trials are discussed.
引用
收藏
页码:209 / 234
页数:26
相关论文
共 128 条
[31]  
FOON KA, 1984, BLOOD, V64, P1085
[32]   IN-VIVO CD40-GP39 INTERACTIONS ARE ESSENTIAL FOR THYMUS-DEPENDENT HUMORAL IMMUNITY .2. PROLONGED SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY AN ANTIBODY TO THE LIGAND FOR CD40, GP39 [J].
FOY, TM ;
SHEPHERD, DM ;
DURIE, FH ;
ARUFFO, A ;
LEDBETTER, JA ;
NOELLE, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1567-1575
[33]  
FRANKEL AE, 1985, J BIOL RESP MODIF, V4, P273
[34]  
FULTON RJ, 1988, CANCER RES, V48, P2626
[35]  
GHETIE MA, 1992, BLOOD, V80, P2315
[36]   DISSEMINATED OR LOCALIZED GROWTH OF A HUMAN B-CELL TUMOR (DAUDI) IN SCID MICE [J].
GHETIE, MA ;
RICHARDSON, J ;
TUCKER, T ;
JONES, D ;
UHR, JW ;
VITETTA, ES .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) :481-485
[37]  
GHETIE MA, 1991, CANCER RES, V51, P5876
[38]  
GHETIE MA, 1994, BLOOD, V83, P1329
[39]  
GHETIE MA, 1988, CANCER RES, V48, P2610
[40]   THE GLP LARGE-SCALE PREPARATION OF IMMUNOTOXINS CONTAINING DEGLYCOSYLATED RICIN-A CHAIN AND A HINDERED DISULFIDE BOND [J].
GHETIE, V ;
THORPE, P ;
GHETIE, MA ;
KNOWLES, P ;
UHR, JW ;
VITETTA, ES .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 142 (02) :223-230